DE1484727U - - Google Patents

Info

Publication number
DE1484727U
DE1484727U DENDAT1484727D DE1484727DU DE1484727U DE 1484727 U DE1484727 U DE 1484727U DE NDAT1484727 D DENDAT1484727 D DE NDAT1484727D DE 1484727D U DE1484727D U DE 1484727DU DE 1484727 U DE1484727 U DE 1484727U
Authority
DE
Germany
Prior art keywords
ttt
mmt
tmt
iii
ttttt
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DENDAT1484727D
Other languages
German (de)
English (en)
Publication of DE1484727U publication Critical patent/DE1484727U/de
Active legal-status Critical Current

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DENDAT1484727D Active DE1484727U (enExample)

Publications (1)

Publication Number Publication Date
DE1484727U true DE1484727U (enExample)

Family

ID=789914

Family Applications (1)

Application Number Title Priority Date Filing Date
DENDAT1484727D Active DE1484727U (enExample)

Country Status (1)

Country Link
DE (1) DE1484727U (enExample)

Similar Documents

Publication Publication Date Title
Yuan et al. Perioperative toripalimab and chemotherapy in locally advanced gastric or gastro-esophageal junction cancer: a randomized phase 2 trial
Rini et al. Phase II study of axitinib in sorafenib-refractory metastatic renal cell carcinoma
Deraco et al. Consensus statement on peritoneal mesothelioma
BRPI0516407A (pt) agonistas de receptor acoplado à proteìna g (gpr116) e uso destes para o tratamento de obesidade e diabetes
Scarpa et al. Role of stapled and hand-sewn anastomoses in recurrence of Crohn's disease.
Roboz et al. Phase 1 study of PTK787/ZK 222584, a small molecule tyrosine kinase receptor inhibitor, for the treatment of acute myeloid leukemia and myelodysplastic syndrome
US10416162B2 (en) Her2 diagnostic methods
MX2021015328A (es) Agonistas del receptor del peptido-1 similar al glucagon.
Krieg et al. CXCR4-A prognostic and clinicopathological biomarker for pancreatic ductal adenocarcinoma: A Meta-Analysis
Davis et al. Randomized phase II trial evaluation of erectile function after attempted unilateral cavernous nerve-sparing retropubic radical prostatectomy with versus without unilateral sural nerve grafting for clinically localized prostate cancer
DE1484727U (enExample)
CA2657324A1 (en) Methods for making cancer prognoses based on subcellular localization of biomarkers
CN102713606A (zh) 用于鉴定、评估、预防和治疗癌症的组合物、试剂盒和方法
Price et al. Current opinion on optimal treatment for colorectal cancer
Protic et al. Prognostic effect of ultra-staging node-negative colon cancer without adjuvant chemotherapy: a prospective National Cancer Institute-sponsored clinical trial
Li et al. Meta-analysis: E-cadherin immunoexpression as a potential prognosis biomarker related to gastric cancer metastasis in Asian patients.
US20250041296A1 (en) Novel dosing regimens for mdm2 inhibitors
Gillespie et al. Incidence of wound dehiscence in patients undergoing laparoscopy or laparotomy: a systematic review and meta-analysis
Liu et al. Discovery of a meisoindigo-derived protac as the ATM degrader: Revolutionizing colorectal cancer therapy via synthetic lethality with ATR inhibitors
Tejpar et al. Integrating biomarkers in colorectal cancer trials in the West and China
Böhm et al. Discovery of novel plasma proteins as biomarkers for the development of incisional hernias after midline incision in patients with colorectal cancer: The ColoCare study
ES2615265T3 (es) Métodos para determinar la probabilidad de supervivencia y para predecir la probabilidad de metástasis en el cáncer
Park et al. Histologic and endoscopic studies before and after gastric bypass surgery.
Veloudis et al. Assessing the clinical utility of Wnt pathway markers in colorectal cancer
Beier et al. Production and characterization of monoclonal antibodies against the antibiotic tilmicosin